News tagged with clinical trials
Related topics: patients , cancer , cancer cells , vaccine , food and drug administration
Study drug is first to help patients with recurrent low-grade ovarian cancer
Low-grade serous ovarian cancer is less common and aggressive than the high-grade variety, yet exceptionally difficult to treat when frontline therapy fails.
Cancer
Feb 08, 2013 |
not rated yet |
0
|
Bevacizumab significantly improves survival for patients with recurrent and metastatic cervical cancer
(Medical Xpress)—Patients with advanced, recurrent, or persistent cervical cancer that was not curable with standard treatment who received the drug bevacizumab (Avastin) lived 3.7 months longer than patients who did not ...
Cancer
Feb 08, 2013 |
not rated yet |
0
Frequent dialysis poses risks for kidney disease patients
Compared with standard dialysis, frequent dialysis can cause complications related to repeated access to the blood, requiring patients to undergo more repair procedures to the site through which blood is removed and returned, ...
Diseases, Conditions, Syndromes
Feb 07, 2013 |
not rated yet |
0
Experimental gene therapy treatment for Duchenne muscular dystrophy offers hope for youngster
Jacob Rutt is a bright 11-year-old who likes to draw detailed maps in his spare time. But the budding geographer has a hard time with physical skills most children take for granted—running and climbing trees are beyond ...
Genetics
Feb 07, 2013 |
5 / 5 (1) |
0
Albumin improves bacterial peritonitis outcomes
(HealthDay)—For patients with spontaneous bacterial peritonitis (SBP), albumin infusion is associated with reduced renal impairment and decreased mortality, according to research published in the February ...
Diseases, Conditions, Syndromes
Feb 07, 2013 |
not rated yet |
0
Reassuring evidence: Anticancer drug does not accelerate tumor growth after treatment ends
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study ...
Cancer
Feb 07, 2013 |
not rated yet |
0
Clot-retrieval devices failed to improve stroke-related disability
A stroke survivor's chances of living independently after 90 days are not improved by the use of devices inserted into the artery to dissolve or remove a stroke-causing clot shortly after the onset of symptoms, according ...
Cardiology
Feb 07, 2013 |
not rated yet |
0
Bionic eye gives hope to the blind
After years of research, the first bionic eye has seen the light of day in the United States, giving hope to the blind around the world.
Ophthalmology
Feb 05, 2013 |
4.5 / 5 (11) |
0
A step towards better understanding of pancreatic cancer
(Medical Xpress)—An international team of scientists has observed that the well-studied protein Sirtuin-1, known for helping cells live longer, also appears to play an important role in pancreatic cancer.
Cancer
Feb 05, 2013 |
5 / 5 (1) |
0
Study suggests glucagon-like peptide-1 receptor agonists related to adolescent weight loss
Preliminary evidence from a clinical trial suggests that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced body mass index and body weight in adolescents with severe obesity, according ...
Pediatrics
Feb 04, 2013 |
not rated yet |
0
Icon to buy division of Cross Country Healthcare
Icon PLC plans to buy the clinical trial services division of Cross Country Healthcare Inc. in a deal potentially worth more than $55 million, as the Irish company seeks to grow globally and improve its drug safety consulting.
Other
Feb 04, 2013 |
not rated yet |
0
Ranibizumab no better than saline for vitreous hemorrhage
(HealthDay)—For patients with vitreous hemorrhage from proliferative diabetic retinopathy (PDR), the probability of vitrectomy within 16 weeks after intravitreal injections of ranibizumab or saline is lower ...
Ophthalmology
Feb 01, 2013 |
not rated yet |
0
Treatment to prevent Alzheimer's disease moves a step closer
(Medical Xpress)—A new drug to prevent the early stages of Alzheimer's disease could enter clinical trials in a few years' time according to scientists.
Alzheimer's disease & dementia
Feb 01, 2013 |
4.7 / 5 (3) |
2
Intervention helps mothers of children diagnosed with cancer
(HealthDay)—Compared with a nondirective support intervention, mothers of children recently diagnosed with cancer who participate in the Bright IDEAS problem-solving skills training (PSST) intervention ...
Cancer
Jan 31, 2013 |
5 / 5 (1) |
0
Tenofovir Gel wins out in drug absorption study, but HIV prevention trials say differently
A novel head-to-head study looking at differences in how the antiretroviral (ARV) drug tenofovir gets absorbed in the body as either an oral tablet or a vaginal gel found tenofovir gel can achieve substantially higher concentrations ...
HIV & AIDS
Jan 30, 2013 |
not rated yet |
0
